SCHEDULE: Harel Insurance Discloses 5.1% Stake in Teva Pharma

Harel Insurance Investments & Financial Services Ltd has reported a 5.1% beneficial ownership stake in Teva Pharmaceutical Industries Ltd, primarily held on behalf of public and client accounts.

Summary

• Harel Insurance Investments & Financial Services Ltd reported a 5.1% beneficial ownership stake in Teva Pharmaceutical Industries Ltd.
• This stake amounts to 58,118,222 Ordinary Shares of Teva Pharmaceutical Industries Ltd.
• The majority of these shares, 56,881,124, are held for members of the public through provident funds, mutual funds, pension funds, insurance policies, and exchange-traded funds managed by Harel's subsidiaries.
• An additional 114,084 Ordinary Shares are held for third-party client accounts managed by a subsidiary, which has no voting power over these securities.
• Harel Insurance beneficially holds 1,123,014 Ordinary Shares for its own account.
• The 5.1% ownership percentage is based on 1,147,150,917 Ordinary Shares issued and outstanding as of June 30, 2025, as reported by Teva Pharmaceutical Industries Ltd.

Sentiment

Score: 7

Explanation: The disclosure of a significant institutional stake by a major financial services firm like Harel Insurance is generally viewed as a positive signal of confidence in the issuer, Teva Pharmaceutical Industries Ltd, by the investment community.

Positives

• A significant institutional investment by Harel Insurance, a major Israeli financial services group, indicates confidence in Teva Pharmaceutical Industries Ltd.
• The substantial portion of the stake held on behalf of public and client accounts suggests broad market exposure and trust in Teva's long-term prospects by Harel's managed funds.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Teva Pharmaceutical Industries Ltd's future performance or Harel Insurance's investment strategy beyond the current ownership disclosure.

Management Comments

• Alon Kaufman, Vice President of Harel Insurance Investments & Financial Services Ltd, certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Teva Pharmaceutical Industries Ltd, nor in connection with any transaction having that purpose or effect.

Industry Context

Teva Pharmaceutical Industries Ltd is a global pharmaceutical company, and Harel Insurance Investments & Financial Services Ltd is a prominent Israeli financial services and insurance group. This disclosure highlights a significant domestic institutional investment in a leading Israeli-based global pharma firm, reflecting potential long-term confidence in the company's market position and prospects within the broader pharmaceutical sector.

Stakeholder Impact

• Shareholders of Teva Pharmaceutical Industries Ltd may view the significant institutional ownership by Harel Insurance as a positive indicator of long-term stability and investor confidence.
• Clients and policyholders of Harel Insurance, whose funds are invested in Teva shares, gain exposure to the pharmaceutical sector through this holding.

Key Dates

Keywords

Teva Pharmaceutical Industries Ltd, Harel Insurance Investments & Financial Services Ltd, Beneficial Ownership, SEC Filing, Pharmaceuticals, Institutional Investment, Ordinary Shares, M8769Q102